Future Scope of Cardiac & Diabetic PCD Pharma Franchise in India – The pharma sector is flourishing at a rapid pace. The drastic rise in various issues like hypertension, diabetes, reproductive disorders, and many more is contributing to the rise in demand for therapeutic products. Therefore, the healthcare industry is witnessing an increase in market size as well as business opportunities.
Upon further examination of the survey results, it has become apparent that, although various segments are expanding, cardiac diabetes has emerged as a more demanding niche. The change in eating habits, overconsumption of alcohol, and several other physiological factors, like lack of sleep, stress, etc., lead to the development of cardiovascular diseases. This directly affects the overall well-being of an individual.
Thus, by entering this business domain, one can not only earn a high profit margin but also create a bridge between pharmaceutical companies and end-users. QndQ Cardia thus presents profitable business deals for establishing a lucrative Cardia Diabetic PCD Franchise at affordable rates.
Future of Cardiac Diabetic PCD Franchise Business in India
Over the years, the death rate due to sudden heart attacks has drastically increased, thereby creating a sense of concern among healthcare professionals. The fluctuations in blood sugar level, lifestyle changes, or any family history could be the main reasons behind the disturbances in cardiovascular health. This particular market is growing at a CAGR of 10%, thus creating a buzz among entrepreneurs to start their franchise business in this field.
By investing a minimal amount, you can start your business in this field and build a lucrative career for yourself. Being recession-proof, it ensures that you gain significant insights in the long run. Also, in the Cardiac Diabetic PCD Franchise, you can avail of business rights that can allow you to target a less competitive zone easily.
You can partner with QndQ Cardia, which is a leading cardiac diabetic company in India, whose flexible offerings could help you build a strong portfolio. Get in touch with us today, and see how your future gets turned into an impactful one.
QndQ Cardia – Go-To Choice for Cardiac Diabetic PCD Pharma Franchise
To mark irreplacable footprints in one of the fastest-growing sectors in India, thus partnering with a trusted company like QndQ Cardia, you can set high standards smoothly. We have ample experience and unwavering expertise in quality. Our manufacturing labs are equipped with high-tech and innovative technology, that makes sure that the overall efficacy of the medication carries no complications. In addition, each product undergoes batch-wise quality testing under the guidelines set by WHO.
We have a vast portfolio that ensures that we cover all the formulations required to manage the cardiovascular health of individuals. Whether you want to target the type-1 diabetic market or the type-2 diabetic market, at our company, you can get all types of combinations that can showcase great efficacy. Explore some of our product ranges; however, to know more, you can schedule a meeting with us today!
| Brand | Composition | Pack |
|---|---|---|
| Cardiac | ||
| Advopin-AT | Atenolol 50 mg + Amlodipine 5 mg | 10×10 Alu-Alu |
| Loskiv-A | Losartan 50 mg + Amlodipine 5 mg | 10×10 Alu-Alu |
| Meptolol-25 SR | Metoprolol SR 25 mg | 10×10 Alu-Alu |
| Meptolol-50 SR | Metoprolol SR 50 mg | 10×10 Alu-Alu |
| Osinet-20 | Olmesartan 20 mg | 10×10 Alu-Alu |
| Rizitat-10 | Rosuvastatin 10 mg | 10×10 Alu-Alu |
| Rizitat-20 | Rosuvastatin 20 mg | 10×10 Alu-Alu |
| Cardoza A | Clopidogrel 75 mg + Aspirin 75 mg | 10×10 Alu-Alu |
| Rabbud 5 | Ramipril 5 mg | 10×10 Alu-Alu |
| Utoptin Gold 10 | Atorvastatin + Aspirin + Clopidogrel | 10×10 Alu-Alu |
| Diabetic | ||
| Biztel-20 | Teneligliptin 20 mg | 10×10 Alu-Alu |
| Uzimet-G2 Forte | Glimepiride 2 mg + Metformin 1000 mg (SR) | 10×10 Alu-Alu |
| Hitlon-M | Dapagliflozin 10 mg + Metformin 500 mg | 10×10 Alu-Alu |
| Dapzime-M | Dapagliflozin 5 mg + Metformin 500 mg | 10×10 Alu-Alu |
| Metzime-G2 | Glimepiride 2 mg + Metformin 500 mg | 10×10 Alu-Alu |
| Metzime-G1 | Glimepiride 1 mg + Metformin 500 mg | 10×10 Alu-Alu |
Open the Gateway to Long-Term Success in Pharma Business with QndQ Cardia
Being a trusted cardiac diabetic pharma franchise company in India, QndQ Cardia provides scalable opportunities to the investors intending to alleviate the rising cardiovascular cases. Shaking hands with us means tapping into the world of profitability that too, in the long run. Under one roof, you can get everything required to give a strong competition in this evolving sector. Some of the qualities are listed below:
ISO-certified Quality – We adhere to top-notch quality standards, ensuring that the medication directly addresses the concerned issue.
Monopoly Rights – Opting for our services, you can get exclusive monopoly rights, allocating you a region that can guarantee seamless, higher returns.
Timely Delivery – Our distribution network is quite strong, carrying all features that ensure delivery across India with uncompromised quality.
Promotional Tools – We provide free marketing tools such as MR kits, visual aids, product samples, and many more, along with complete training about the newer trends to boost your pharma sales.
Good Market Reputation – At QndQ Cardia, we have a strong market presence, which gives you the leverage to build a large customer base.
So, if you want to start a PCD Franchise business in the Cardiac Diabetic range, then there could be no better option than us. Use the details mentioned below:
Address: Plot No. 158, Industrial Area Phase-I, Panchkula, Haryana
Mobile Number: +91-9816857058
Email: qndqcardia@gmail.com
